Eczema cream containing sophora flavescens extract as well as preparation method and application of eczema cream

By developing O/W type eczema cream containing Sophora ginseng extract, the problems of drug dependence and cumbersome operation in existing eczema treatment methods have been solved, and the therapeutic effect with high stability, strong antibacterial properties and significant transdermal absorption effect has been achieved. An effective treatment plan for eczema is provided.

CN118986846APending Publication Date: 2024-11-22GUANGZHOU XI HAI BIO&TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410776991.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-17
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Among the existing treatment methods for eczema, Western medicine ointments have problems with drug dependence and drug discontinuation reactions. The external use of Chinese herbal medicines is cumbersome and inconvenient, and lacks effective, stable and side effects.

Method used

Develop an eczema cream containing Sophora ginseng extract, using shea butter, lanolin, stearic acid, octadecanol, Tween-60, Sipan-80, borneol, glycerin, Hansheng gum, Sophora ginseng extract O/W cream is prepared by combining the aqueous phase and the oil phase, and the various pharmacological effects of Sophora glutinous rice are used to treat eczema.

Benefits of technology

The prepared eczema cream has good stability, strong antibacterial properties, and significant transdermal absorption effect. It can effectively inhibit ear inflammation in mice triggered by croton oil, and provide a quick and effective and gentle therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118986846A_ABST
    Figure CN118986846A_ABST
Patent Text Reader

Abstract

The invention discloses eczema cream containing a sophora flavescens extract as well as a preparation method and application of the eczema cream. The eczema cream is prepared from the following components: shea butter, wool fat, stearic acid, octadecanol, tween-60, span-80, borneol, glycerol, xanthan gum, the sophora flavescens extract, 1, 2-hexanediol, peppermint essence and distilled water. According to the preparation method of the eczema cream containing the sophora flavescens extract and the preparation method of the eczema cream containing the sophora flavescens extract, the eczema cream containing the sophora flavescens extract and the preparation method and application of the eczema cream containing the sophora flavescens extract are improved by optimizing a formula and adding new components, and the eczema cream containing the sophora flavescens extract and the preparation method and application of the
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to an eczema cream containing a sophora flavescens extract, and a preparation method and application thereof. Background Art

[0002] There is currently no cure for eczema, and the true cause of eczema is currently unknown. It is usually caused by complex internal and external stimuli.

[0003] The most commonly used topical treatment is Western medicine ointment. Although hormone-based Western medicine ointments are effective quickly, they can cause drug dependence and withdrawal reactions and are not suitable for long-term use. If eczema develops into chronic eczema and requires long-term medication, Western medicine ointments are not suitable.

[0004] The oral administration of Chinese herbal medicine has a slow effect and cannot directly contact damaged skin. The external application of Chinese medicine, such as Chinese herbal washing and Chinese herbal fumigation bath, is cumbersome and not portable. Therefore, ointments made from Chinese herbal medicine can effectively avoid these shortcomings. At the same time, compared with Western medicine ointments, they have the advantages of fast effect, mild medicinal properties, no skin irritation and no side effects. Therefore, it is necessary to develop Chinese herbal ointments with precise efficacy, high drug stability and few adverse reactions. Summary of the Invention

[0005] In view of the deficiencies in the prior art, the purpose of the present invention is to provide an eczema ointment containing Sophora flavescens extract with definite efficacy, high drug stability and few adverse reactions, as well as a preparation method and application thereof.

[0006] The technical solution adopted by the present invention to solve its technical problem is:

[0007] An eczema cream containing Sophora flavescens extract, comprising the following ingredients:

[0008] Shea butter, lanolin, stearic acid, octadecyl alcohol, Tween-60, Span-80, borneol, glycerin, xanthan gum, sophora flavescens extract, 1,2-hexanediol, mint flavor, distilled water.

[0009] Preferably, the invention comprises the following ingredients in weight percentage: shea butter: 3.0%-4.0%, lanolin: 1.5%-2.5%, stearic acid: 0.5%-1.5%, octadecyl alcohol: 4.0%-6.0%, Tween-60: 3.5%-4.5%, Span-80: 0.5%-1.5%, borneol: 0.3%-0.5%, glycerol: 6.5%-7.5%, xanthan gum: 0.05%-0.2%, sophora flavescens extract: 4.0%-5.0%, 1,2-hexanediol: 4.5%-5.5%, mint essence: 0.05%-0.2%, and the balance is distilled water.

[0010] Preferably, the invention comprises the following ingredients in weight percentage: shea butter: 3.5%, lanolin: 2.0%, stearic acid: 1.0%, octadecyl alcohol: 5.0%, Tween-60: 4.0%, Span-80: 1.0%, borneol: 0.4%, glycerin: 7.0%, xanthan gum: 0.1%, sophora flavescens extract: 4.5%, 1,2-hexanediol: 5.0%, mint essence: 0.1%, and the balance is distilled water.

[0011] Preferably, the invention comprises the following ingredients in weight percentage: shea butter: 3.0%, lanolin: 2.5%, stearic acid: 1.5%, octadecyl alcohol: 4.5%, Tween-60: 3.5%, Span-80: 1.0%, borneol: 0.4%, glycerin: 7.0%, xanthan gum: 0.1%, sophora flavescens extract: 4.0%, 1,2-hexanediol: 5.5%, mint essence: 0.2%, and the balance is distilled water.

[0012] Preferably, the invention comprises the following ingredients in weight percentage: shea butter: 4.0%, lanolin: 1.5%, stearic acid: 1.0%, octadecyl alcohol: 6.0%, Tween-60: 4.5%, Span-80: 1.5%, borneol: 0.5%, glycerin: 6.5%, xanthan gum: 0.15%, sophora flavescens extract: 5.0%, 1,2-hexanediol: 4.5%, mint essence: 0.1%, and the balance is distilled water.

[0013] Another technical problem to be solved by the present invention is to provide a method for preparing an eczema cream containing a Sophora flavescens extract, comprising the following steps:

[0014] Melt shea butter, lanolin, stearic acid, octadecanol, Tween-60, Span-80 and borneol in a water bath at 80° C. to form an oil phase;

[0015] Stir glycerin, xanthan gum, distilled water, and Sophora flavescens extract and slowly heat to 80°C to obtain an aqueous phase;

[0016] Add the aqueous phase into the oil phase and stir to form a cream, then add 1,2-hexanediol and mint essence and stir thoroughly to obtain the cream.

[0017] Preferably, the preparation method of the Sophora flavescens extract comprises: soaking Sophora flavescens powder for 4-6 hours, adding 8-12 times the amount of water, and decocting once for 1-2 hours. After decoction, the mixture is centrifuged at 3000 rpm for 8-12 minutes, and the supernatant is collected to obtain the Sophora flavescens extract.

[0018] Another technical problem to be solved by the present invention is to provide a method for preparing an eczema cream containing a Sophora flavescens extract, comprising the following steps:

[0019] Melt shea butter, lanolin, stearic acid, octadecanol, Tween-60 and Span-80 in a water bath at 80°C to form an oil phase;

[0020] Stir glycerin, xanthan gum, distilled water, and Sophora flavescens extract and slowly heat to 80°C to obtain an aqueous phase;

[0021] Add the aqueous phase into the oil phase and stir to form a cream, then add 1,2-hexanediol and mint essence and stir thoroughly to obtain the cream.

[0022] Another technical problem to be solved by the present invention is to provide a method for preparing an eczema cream containing a Sophora flavescens extract, comprising the following steps:

[0023] Melt shea butter, lanolin, stearic acid, octadecanol, Tween-60, Span-80 and borneol in a water bath at 80° C. to form an oil phase;

[0024] Stir glycerin, xanthan gum, distilled water, and Sophora flavescens extract and slowly heat to 80°C to obtain an aqueous phase;

[0025] Add the water phase into the oil phase and stir to form a cream, then add mint essence and stir thoroughly.

[0026] Another technical problem to be solved by the present invention is to provide an application of the above-mentioned eczema cream containing Sophora flavescens extract in medicine for treating skin eczema.

[0027] (2) Pharmacological effects of Sophora flavescens

[0028] 1. Antibacterial effect

[0029] The matrine and flavonoids contained in Sophora flavescens can inhibit the activity of most bacteria and have a wide range of antibacterial effects. The main mechanism of action of Sophora flavescens is to inhibit the formation of bacterial biofilms, inhibit protein synthesis, and destroy cell walls.

[0030] 2. Hypoglycemic effect

[0031] The matrine and flavonoids contained in Sophora flavescens have the effect of lowering blood sugar by promoting the phosphorylation of key molecules of insulin signaling, upregulating insulin receptors, improving insulin resistance, and promoting the metabolism of sugar in tissues and cells.

[0032] 3. Lipid-lowering effect

[0033] Matrine contained in Sophora flavescens has the effect of lowering blood lipids. By reducing the expression of cyclooxygenase II, it can reduce the concentration of cholesterol, triglycerides, low-density lipoprotein, and increase the concentration of high-density lipoprotein, and can promote atherosclerosis and coagulation system.

[0034] 4. Anti-inflammatory Effects

[0035] The matrine and flavonoids contained in Sophora flavescens have anti-inflammatory properties. They achieve this by reducing blood levels of pro-inflammatory factors such as interleukin-6 and tumor necrosis factor-α and increasing levels of anti-inflammatory factors such as interleukin-10. In gynecology, it can be used to treat bacterial vaginosis and protect vaginal epithelial cells.

[0036] 5. Antioxidant Effect

[0037] The flavonoids in Sophora flavescens have antioxidant properties. They increase the activity of superoxide dismutase and glutathione peroxidase, thus achieving an antioxidant effect. They also have the effect of alleviating liver damage.

[0038] 6. Antiviral Effect

[0039] Matrine and sophoridine contained in Sophora flavescens have antiviral effects. They achieve this by reducing the activity of extracellular regulatory protein kinases and inhibiting their phosphorylation. Sophora flavescens is effective against both RNA and DNA viruses, directly inactivating and inhibiting viral replication and proliferation.

[0040] 7. Anti-tumor effects

[0041] Matrine and oxymatrine contained in Sophora flavescens have anti-tumor effects. They achieve their anti-tumor effects by inhibiting the phosphorylation of cell proliferation-related protein kinases and extracellular regulatory protein kinase proteins, interfering with the cell cycle, and inducing tumor cell apoptosis.

[0042] 8. Sedative and hypnotic effects

[0043] The oxidized sophoridine, matrine, oxymatrine, and flavonoids contained in Sophora flavescens have sedative and hypnotic effects. They inhibit the activity of hippocampal nerve cells to inhibit the central nervous system and treat insomnia.

[0044] 9. Analgesic effect

[0045] Matrine, oxymatrine, sophoracarpine, oxysophoracarpine, and sophoridine contained in Sophora flavescens have analgesic effects. This analgesic effect is non-addictive and non-drug-tolerant, independent of opioid receptors, and increases the threshold for mechanical and thermal pain.

[0046] 10. Immunomodulatory effects

[0047] Matrine contained in Sophora flavescens has an immunomodulatory effect. At low doses, it has an immunostimulatory effect, while at high doses, it has an immunosuppressive effect. Therefore, Sophora flavescens has a bidirectional regulatory effect on immunomodulation.

[0048] 11. Improve memory function

[0049] Matrine, oxymatrine, and flavonoids contained in Sophora flavescens can improve memory function by stabilizing cell membranes, reducing oxidative stress damage, reducing lipid peroxidation, and resisting oxygen free radicals.

[0050] 12. Protective effect on the heart

[0051] Matrine and oxymatrine contained in Sophora flavescens have cardioprotective effects. They can improve heart failure, protect myocardial cells, have broad-spectrum anti-arrhythmic effects, and reverse ventricular remodeling.

[0052] 13. Antiasthmatic effect

[0053] Matrine, oxymatrine and sophocarpine contained in Sophora flavescens have antiasthmatic effects. They can inhibit phosphodiesterase activity, counteract the excitation of tracheal smooth muscle and stimulate central β receptors.

[0054] 14. Anti-fertility effect

[0055] Sophora flavescens contains alopecurine and oxymatrine, which have anti-fertility effects. They can reduce female fertility and have spermicidal effects when reaching a certain concentration.

[0056] The beneficial effects of the present invention are:

[0057] Based on the problems of current eczema cream treatment, this paper proposes to make eczema cream with the Chinese herbal medicine Sophora flavescens as the main ingredient and explore its efficacy in treating eczema. Because allergic inflammatory reactions are exudative, W / O type creams cannot be used. Therefore, this scheme adopts the method of adding water phase to oil phase to make eczema cream;

[0058] The quality evaluation of the eczema cream included appearance inspection, stability testing, pH measurement, and antibacterial performance testing. The results showed a uniform and fine texture, a slight minty aroma, suitable fluidity, good stability, and a pH within the normal range. The antibacterial performance test was conducted by using the preservative 1,2-hexanediol as a variable to produce different eczema creams. The results showed that the eczema cream with the preservative had stronger antibacterial properties than the one without.

[0059] Animal experiments were conducted with borneol, a transdermal absorption enhancer, as a variable to explore the effects of eczema ointment with or without a transdermal absorber on croton oil-induced ear inflammation in mice. The results showed that the eczema ointment made with Sophora flavescens as the main ingredient had an inhibitory effect on croton oil-induced ear inflammation in mice, and the efficacy of the eczema ointment with the addition of a transdermal absorber was stronger than that without the addition of a transdermal absorber. BRIEF DESCRIPTION OF THE DRAWINGS

[0060] Figure 1 Schematic diagram of the eczema cream containing Sophora flavescens extract prepared in Example 1;

[0061] Figure 2This is a schematic diagram of the eczema cream containing Sophora flavescens extract prepared in Comparative Example 1;

[0062] Figure 3 This is a schematic diagram of the eczema cream containing Sophora flavescens extract prepared in Comparative Example 2;

[0063] Figure 4 This is a schematic diagram of the eczema cream before the heat resistance test;

[0064] Figure 5 This is a schematic diagram of the eczema cream after the heat resistance test;

[0065] Figure 6 This is a schematic diagram of the eczema cream before the cold resistance experiment;

[0066] Figure 7 This is a schematic diagram of the eczema cream after the cold resistance experiment;

[0067] Figure 8 This is a schematic diagram of the eczema cream before the centrifugation experiment;

[0068] Figure 9 This is a schematic diagram of the eczema cream after centrifugation experiment;

[0069] Figure 10 This is a diagram of pH measurement of eczema cream;

[0070] Figure 11 This is a schematic diagram of the eczema cream containing Sophora flavescens extract prepared in Comparative Example 2 after being left for a period of time;

[0071] Figure 12 This is a comparison chart of the effects of eczema ointment on inflammatory response in the ears of mice induced by croton oil;

[0072] Figure 13 This is a comparison chart of the effects of eczema ointment on the inflammatory response in the ears of mice induced by croton oil. DETAILED DESCRIPTION

[0073] The principles and features of the present invention are described below. The examples provided are intended to illustrate the present invention only and are not intended to limit the scope of the present invention. The following paragraphs describe the present invention in more detail by way of example. The advantages and features of the present invention will become more apparent from the following description and claims.

[0074] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which this invention pertains. The terms used in this specification of the present invention are for the purpose of describing specific embodiments only and are not intended to limit the present invention. The term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0075] Example 1

[0076] See Figure 1 As shown, an eczema cream containing Sophora flavescens extract includes the following ingredients in weight percentage: shea butter: 3.5%, lanolin: 2.0%, stearic acid: 1.0%, octadecyl alcohol: 5.0%, Tween-60: 4.0%, Span-80: 1.0%, borneol: 0.4%, glycerin: 7.0%, xanthan gum: 0.1%, Sophora flavescens extract: 4.5%, 1,2-hexanediol: 5.0%, mint essence: 0.1%, and the balance is distilled water.

[0077] A method for preparing an eczema cream containing a Sophora flavescens extract comprises the following steps:

[0078] Melt shea butter, lanolin, stearic acid, octadecanol, Tween-60, Span-80 and borneol in a water bath at 80° C. to form an oil phase;

[0079] Stir glycerin, xanthan gum, distilled water, and Sophora flavescens extract and slowly heat to 80°C to obtain an aqueous phase;

[0080] Add the aqueous phase into the oil phase and stir to form a cream, then add 1,2-hexanediol and mint essence and stir thoroughly to obtain the cream.

[0081] The preparation method of the Sophora flavescens extract comprises: soaking Sophora flavescens powder for 4-6 hours, adding 8-12 times the amount of water, and decocting once for 1-2 hours. After decocting, the powder is centrifuged at a speed of 3000 r / min for 8-12 minutes, and the supernatant is collected to obtain the Sophora flavescens extract.

[0082] Example 2

[0083] The invention discloses an eczema cream containing a sophora flavescens extract, comprising the following ingredients in percentage by weight: shea butter: 3.0%, lanolin: 2.5%, stearic acid: 1.5%, octadecyl alcohol: 4.5%, Tween-60: 3.5%, Span-80: 1.0%, borneol: 0.4%, glycerol: 7.0%, xanthan gum: 0.1%, sophora flavescens extract: 4.0%, 1,2-hexanediol: 5.5%, mint essence: 0.2%, and the balance being distilled water.

[0084] A method for preparing an eczema cream containing a Sophora flavescens extract comprises the following steps:

[0085] Melt shea butter, lanolin, stearic acid, octadecanol, Tween-60, Span-80 and borneol in a water bath at 80° C. to form an oil phase;

[0086] Stir glycerin, xanthan gum, distilled water, and Sophora flavescens extract and slowly heat to 80°C to obtain an aqueous phase;

[0087] Add the aqueous phase into the oil phase and stir to form a cream, then add 1,2-hexanediol and mint essence and stir thoroughly to obtain the cream.

[0088] The preparation method of the Sophora flavescens extract comprises: soaking Sophora flavescens powder for 4-6 hours, adding 8-12 times the amount of water, and decocting once for 1-2 hours. After decocting, the powder is centrifuged at a speed of 3000 r / min for 8-12 minutes, and the supernatant is collected to obtain the Sophora flavescens extract.

[0089] Example 3

[0090] The invention discloses an eczema cream containing a sophora flavescens extract, comprising the following ingredients in percentage by weight: shea butter: 4.0%, lanolin: 1.5%, stearic acid: 1.0%, octadecyl alcohol: 6.0%, Tween-60: 4.5%, Span-80: 1.5%, borneol: 0.5%, glycerin: 6.5%, xanthan gum: 0.15%, sophora flavescens extract: 5.0%, 1,2-hexanediol: 4.5%, mint essence: 0.1%, and the balance being distilled water.

[0091] A method for preparing an eczema cream containing a Sophora flavescens extract comprises the following steps:

[0092] Melt shea butter, lanolin, stearic acid, octadecanol, Tween-60, Span-80 and borneol in a water bath at 80° C. to form an oil phase;

[0093] Stir glycerin, xanthan gum, distilled water, and Sophora flavescens extract and slowly heat to 80°C to obtain an aqueous phase;

[0094] Add the aqueous phase into the oil phase and stir to form a cream, then add 1,2-hexanediol and mint essence and stir thoroughly to obtain the cream.

[0095] The preparation method of the Sophora flavescens extract comprises: soaking Sophora flavescens powder for 4-6 hours, adding 8-12 times the amount of water, and decocting once for 1-2 hours. After decocting, the powder is centrifuged at a speed of 3000 r / min for 8-12 minutes, and the supernatant is collected to obtain the Sophora flavescens extract.

[0096] Comparative Example 1

[0097] See Figure 2 As shown, an eczema cream containing Sophora flavescens extract includes the following ingredients: the following ingredients in weight percentage: shea butter: 3.5%, lanolin: 2.0%, stearic acid: 1.0%, octadecyl alcohol: 5.0%, Tween-60: 4.0%, Span-80: 1.0%, glycerin: 7.0%, xanthan gum: 0.1%, Sophora flavescens extract: 4.5%, 1,2-hexanediol: 5.0%, mint essence: 0.1%, and the balance is distilled water.

[0098] A method for preparing an eczema cream containing a Sophora flavescens extract comprises the following steps:

[0099] Melt shea butter, lanolin, stearic acid, octadecanol, Tween-60 and Span-80 in a water bath at 80°C to form an oil phase;

[0100] Stir glycerin, xanthan gum, distilled water, and Sophora flavescens extract and slowly heat to 80°C to obtain an aqueous phase;

[0101] Add the aqueous phase into the oil phase and stir to form a cream, then add 1,2-hexanediol and mint essence and stir thoroughly to obtain the cream.

[0102] Comparative Example 2

[0103] See Figure 3 As shown, an eczema cream containing Sophora flavescens extract includes the following ingredients: the following ingredients in weight percentage: shea butter: 3.5%, lanolin: 2.0%, stearic acid: 1.0%, octadecyl alcohol: 5.0%, Tween-60: 4.0%, Span-80: 1.0%, borneol: 0.4%, glycerin: 7.0%, xanthan gum: 0.1%, Sophora flavescens extract: 4.5%, mint essence: 0.1%, and the balance is distilled water.

[0104] A method for preparing an eczema cream containing a Sophora flavescens extract comprises the following steps:

[0105] Melt shea butter, lanolin, stearic acid, octadecanol, Tween-60, Span-80 and borneol in a water bath at 80° C. to form an oil phase;

[0106] Stir glycerin, xanthan gum, distilled water, and Sophora flavescens extract and slowly heat to 80°C to obtain an aqueous phase;

[0107] Add the water phase into the oil phase and stir to form a cream, then add mint essence and stir thoroughly.

[0108] Table 1 Component analysis results

[0109]

[0110]

[0111] Table 2 Appearance inspection results

[0112]

[0113] Experimental example

[0114] Heat resistance test

[0115] The samples prepared in Example 1 and Comparative Examples 1-2 were placed in an environment at 55° C. for 6 hours, and the changes of the samples before and after the heat-resistant reaction were observed.

[0116] The results are as follows Figure 4-5 As shown: enhanced fluidity and no oil-water separation.

[0117] Cold resistance experiment

[0118] The samples prepared in Example 1 and Comparative Examples 1-2 were placed in an environment of -15°C for 24 hours, and the changes of the samples before and after the cold resistance reaction were observed.

[0119] The results are as follows Figure 6-7 As shown: there is no obvious change and no oil-water separation phenomenon.

[0120] Centrifugation experiment

[0121] The samples prepared in Example 1 and Comparative Examples 1-2 were placed in centrifuge tubes and centrifuged at 2500 r·min-1 for 10 min. The changes of the samples before and after centrifugation were observed.

[0122] The results are as follows Figure 8-9 Shown: No significant changes.

[0123] Centrifugation experiment

[0124] The samples prepared in Example 1 and Comparative Examples 1-2 were placed in centrifuge tubes and centrifuged at 2500 r·min-1 for 10 min. The changes of the samples before and after centrifugation were observed.

[0125] The results are as follows Figure 10-11 Shown: No significant changes.

[0126] pH measurement

[0127] The pH values ​​of the samples obtained in Example 1 and Comparative Examples 1-2 are as follows: Since the samples obtained in Example 1 and Comparative Examples 1-2 are all O / W creams, the pH of a standard O / W cream is not greater than 8.3.

[0128] The results are as follows Figure 12 As shown: PH is within the qualified range.

[0129] Antibacterial properties

[0130] The eczema cream of Example 1 was added with the preservative 1,2-hexanediol, while the eczema cream of Comparative Example 2 was not added with any preservative. The eczema cream of Example 1 and the eczema cream of Comparative Example 2 were left for a period of time.

[0131] The results are as follows Figure 13 As shown: the eczema cream of comparative example 2 has deteriorated, while eczema cream 1 has no change

[0132] Experimental Example 2

[0133] Effects of eczema ointment on croton oil-induced ear inflammation in mice

[0134] Experimental Materials

[0135] (1) Experimental animals

[0136] Clean-grade Kunming mice, half male and half female, 6 months old, provided by the Experimental Animal Center of Southern Medical University

[0137] (2) Experimental reagents

[0138] Croton oil, homemade eczema cream 1, homemade eczema cream 2, distilled water, etc.

[0139] (3) Experimental instruments

[0140] Hole punch, analytical balance, surgical scissors, mouse cage, cotton swabs

[0141] 2. Experimental Principle

[0142] (1) Mouse ear swelling model

[0143] There are two types of inflammation: infectious inflammation, which is caused by infection, and non-infectious inflammation, which is not caused by infection. Non-infectious inflammation is further divided into nonspecific inflammation and allergic inflammation, both of which manifest as redness, swelling, heat, pain, and functional impairment. Inflammation is, to some extent, a protective effect of the human immune system and is beneficial. However, severe inflammatory reactions can also cause damage to the body, making anti-inflammatory drugs essential.

[0144] The human body will not produce allergic symptoms when it comes into contact with allergens for the first time, but when the human body comes into contact with allergens for the second time, it will produce an allergic reaction, that is, an allergic reaction. The response of the immune system will stimulate the body to become inflamed. This type of inflammation is allergic inflammation, which is a non-specific inflammation.

[0145] The mouse ear swelling model is a model of nonspecific acute inflammation. It uses a chemical substance, croton oil, as an inflammatory agent in this study to induce ear swelling in mice. This model is currently used to evaluate the efficacy of certain anti-inflammatory drugs. Therefore, the mouse ear swelling model is an excellent tool for evaluating the anti-inflammatory effects of anti-allergic drugs.

[0146] (II) Commonly used inflammatory agents and their inflammatory mechanisms

[0147] 1. Croton oil

[0148] Croton oil has three inflammatory mechanisms. Croton oil can promote the release of inflammatory mediators such as histamine and 5-hydroxytryptamine, thereby dilating blood vessels and increasing capillary permeability. It can induce the release of AA, which is metabolized into prostaglandin E2 (PGE2) and leukotrienes (LTB4) under the action of cyclooxygenase (COX) and 5-lipoxygenase (5-LOX). PGE2 will strongly dilate blood vessels and increase vascular permeability, causing heat and pain. LTB4 will increase vascular permeability and have a chemotactic effect on white blood cells. It can induce the body to produce inflammatory cytokines such as TNF-α, IL-1β and IL-6, which have a chemotactic effect on white blood cells.

[0149] 2. Xylene

[0150] Xylene can release certain inflammatory mediators, which will cause local vasodilation in the human body, increase the permeability of capillaries, and cause infiltration of inflammatory cells, eventually forming acute exudative inflammatory edema in the ear.

[0151] Xylene is a low-cost inflammatory agent and is simple to model. However, there are large individual differences in ear swelling and the duration of ear swelling is relatively short, making it unsuitable for drugs with slow anti-inflammatory effects.

[0152] 3. Experimental steps

[0153] (1) Give eczema ointment

[0154] Mice were randomly divided into three groups (three male mice each): a blank group, an eczema cream group 1, and an eczema cream group 2. The eczema cream group 1 group received eczema cream 1 in the right ear for seven consecutive days, while the eczema cream group 2 received eczema cream 2 in the right ear for seven consecutive days.

[0155] (2) Establishment of mouse ear swelling model

[0156] One hour after the last drug administration, 50 μl of croton oil was taken up with a pipette and evenly applied to the front and back of the left and right ears of the mice. The mice were then killed by pulling their necks 5 hours after application.

[0157] (3) Comparison of redness and swelling of the two ears of mice

[0158] Use scissors to cut off the left and right ears of the mouse and weigh each ear using a precision electronic balance. Use a hole punch to cut the mouse's ears at roughly the same location, ensuring that the cut pieces are of the same size. In this experiment, the ear pieces cut with the hole punch are circular. Place the ear pieces on a precision electronic balance for weighing.

[0159] (IV) Calculation of swelling degree and swelling rate

[0160] Swelling degree = weight of left ear piece - weight of right ear piece.

[0161] Swelling inhibition rate = swelling degree / right ear weight.

[0162] 4. Experimental results Figure 12-13 , and Table 3 below.

[0163] Table 3 Effect of eczema ointment on inflammatory response in mice ears induced by croton oil

[0164]

[0165] The data in the table show that, compared to the blank group, both Eczema Cream Group 1 and Eczema Cream Group 2 showed an inhibitory effect on croton oil-induced ear inflammation in mice. Therefore, it can be concluded that the Eczema Cream made with Sophora flavescens as its primary ingredient does have an inhibitory effect on inflammation. Eczema Cream Group 1, which included the transdermal absorbent borneol, showed a stronger anti-inflammatory effect than Eczema Cream Group 2, which did not. This suggests that the addition of a transdermal absorbent may aid drug absorption, leading to a better inhibitory effect on inflammation.

[0166] The above embodiments of the present invention are not intended to limit the scope of protection of the present invention, and the implementation methods of the present invention are not limited thereto. All other modifications, replacements or changes made to the above structures of the present invention based on the above contents of the present invention, in accordance with common technical knowledge and customary means in this field, without departing from the above basic technical ideas of the present invention, should fall within the scope of protection of the present invention.

Claims

1. An eczema cream containing Sophora flavescens extract, characterized in that: Includes the following ingredients: Shea butter, lanolin, stearic acid, octadecyl alcohol, Tween-60, Span-80, borneol, glycerin, xanthan gum, sophora flavescens extract, 1,2-hexanediol, mint flavor, distilled water.

2. The eczema cream containing Sophora flavescens extract according to claim 1, characterized in that: The invention comprises the following ingredients in weight percentage: shea butter: 3.0%-4.0%, lanolin: 1.5%-2.5%, stearic acid: 0.5%-1.5%, octadecyl alcohol: 4.0%-6.0%, Tween-60: 3.5%-4.5%, Span-80: 0.5%-1.5%, borneol: 0.3%-0.5%, glycerol: 6.5%-7.5%, xanthan gum: 0.05%-0.2%, sophora flavescens extract: 4.0%-5.0%, 1,2-hexanediol: 4.5%-5.5%, mint essence: 0.05%-0.2%, and the balance is distilled water.

3. The eczema cream containing Sophora flavescens extract according to claim 1, characterized in that: The invention comprises the following ingredients in percentage by weight: shea butter: 3.5%, lanolin: 2.0%, stearic acid: 1.0%, octadecyl alcohol: 5.0%, Tween-60: 4.0%, Span-80: 1.0%, borneol: 0.4%, glycerol: 7.0%, xanthan gum: 0.1%, sophora flavescens extract: 4.5%, 1,2-hexanediol: 5.0%, mint flavor: 0.1%, the balance is distilled water.

4. The eczema cream containing Sophora flavescens extract according to claim 1, characterized in that: The invention comprises the following ingredients in weight percentage: shea butter: 3.0%, lanolin: 2.5%, stearic acid: 1.5%, octadecyl alcohol: 4.5%, Tween-60: 3.5%, Span-80: 1.0%, borneol: 0.4%, glycerol: 7.0%, xanthan gum: 0.1%, sophora flavescens extract: 4.0%, 1,2-hexanediol: 5.5%, peppermint essence: 0.2%, and the balance is distilled water.

5. The eczema cream containing Sophora flavescens extract according to claim 1, characterized in that: The invention comprises the following ingredients in percentage by weight: shea butter: 4.0%, lanolin: 1.5%, stearic acid: 1.0%, octadecyl alcohol: 6.0%, Tween-60: 4.5%, Span-80: 1.5%, borneol: 0.5%, glycerol: 6.5%, xanthan gum: 0.15%, sophora flavescens extract: 5.0%, 1,2-hexanediol: 4.5%, peppermint essence: 0.1%, and the balance is distilled water.

6. A method for preparing an eczema cream containing a Sophora flavescens extract, characterized in that: The following steps are involved: Melt shea butter, lanolin, stearic acid, octadecyl alcohol, Tween-60, Span-80 and borneol in a water bath at 80° C. to form an oil phase; Glycerin, xanthan gum, distilled water, and Sophora flavescens extract were stirred and slowly heated to 80°C to obtain an aqueous phase; Add the water phase into the oil phase and stir to form a cream, then add 1,2-hexanediol and mint essence and stir thoroughly to obtain a cream.

7. The method for preparing the eczema cream containing Sophora flavescens extract according to claim 5, characterized in that: The preparation method of the sophora flavescens extract is as follows: soak the sophora flavescens powder for 4-6 hours, add 8-12 times of water, decoct once, and the decoction time is 1-2 hours. After decoction, centrifuge at a speed of 3000r / min for 8-12 minutes, and then take the supernatant to obtain the sophora flavescens extract.

8. A method for preparing an eczema cream containing a Sophora flavescens extract, characterized in that: The following steps are involved: Melt shea butter, lanolin, stearic acid, octadecyl alcohol, Tween-60 and Span-80 in a water bath at 80° C. to form an oil phase; Glycerin, xanthan gum, distilled water, and Sophora flavescens extract were stirred and slowly heated to 80°C to obtain an aqueous phase; Add the water phase into the oil phase and stir to form a cream, then add 1,2-hexanediol and mint essence and stir thoroughly to obtain a cream.

9. A method for preparing an eczema cream containing a Sophora flavescens extract, characterized in that: The following steps are involved: Melt shea butter, lanolin, stearic acid, octadecyl alcohol, Tween-60, Span-80 and borneol in a water bath at 80° C. to form an oil phase; Glycerin, xanthan gum, distilled water, and Sophora flavescens extract were stirred and slowly heated to 80°C to obtain an aqueous phase; Add the water phase into the oil phase and stir to form a cream, then add mint essence and stir thoroughly to obtain a cream.

10. Use of the eczema cream containing Sophora flavescens extract according to any one of claims 1 to 8 in a medicine for treating skin eczema.